2 more dead of COVID-19 in Bohol | Inquirer News

2 more dead of COVID-19 in Bohol

By: - Correspondent / @leoudtohanINQ
07:31 PM April 15, 2021

TAGBILARAN CITY—Two more persons died of COVID-19 in the province of Bohol.

According to Dr. Cesar Tomas Lopez, spokesperson of  the province’s Inter-Agency Task Force for the Management of Emerging Infectious Diseases, the new fatalities were two senior citizens from Tubigon town and Tagbilaran City.

They died on Wednesday (April 14) while being admitted at the Governor Celestino Gallares Memorial Hospital.

Article continues after this advertisement

As of Thursday, Bohol has 303 active COVID-19 cases.

FEATURED STORIES

“This clearly affirms the presence of the virus in the community,” he said.

Lopez said the total COVID-19 cases in Bohol has reached 1,845 with 1,511 recoveries and 31 deaths.

Article continues after this advertisement

Tagbilaran, the provincial capital, has the highest number of infections with 27 cases.

Lopez urged residents to heed health protocols for their own protection.

TSB
Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our daily newsletter

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

For more news about the novel coronavirus click here.
What you need to know about Coronavirus.
For more information on COVID-19, call the DOH Hotline: (02) 86517800 local 1149/1150.

The Inquirer Foundation supports our healthcare frontliners and is still accepting cash donations to be deposited at Banco de Oro (BDO) current account #007960018860 or donate through PayMaya using this link.

TAGS: Bohol, COVID-19, deaths, pandemic, Regions, seniors

Your subscription could not be saved. Please try again.
Your subscription has been successful.

Subscribe to our newsletter!

By providing an email address. I agree to the Terms of Use and acknowledge that I have read the Privacy Policy.

© Copyright 1997-2024 INQUIRER.net | All Rights Reserved

This is an information message

We use cookies to enhance your experience. By continuing, you agree to our use of cookies. Learn more here.